NEW YORK – Researchers at Yale and Rutgers universities have developed a fast method to detect rare disease-causing point mutations directly from blood. Using a novel amplification technology coupled ...

NEW YORK – Qiagen announced on Wednesday that it has launched a third-party partnering program for its clinical digital PCR platform and signed an agreement with the program's inaugural partner, South ...

NEW YORK – The US Department of Justice said Wednesday that a Chicago lab owner has been sentenced to seven years in prison for his role in a COVID-19 testing fraud. During 2021 and 2022, lab owner ...

NEW YORK – In a letter to customers on Wednesday, Bio-Rad Laboratories announced that it has decided against implementing a tariff surcharge that the company on May 21 said it was considering for at ...

NEW YORK – Grail on Wednesday reported positive topline performance and safety results from its Pathfinder 2 study, finding that adding its multi-cancer early detection (MCED) test to standard-of-care ...

The company uses artificial intelligence to detect metabolic patterns from urine samples that indicate prostate cancer.

The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.